Many MSME pharma firms making substandard drugs, CDSCO data shows

Data from the CDSCO reveals that numerous MSME pharmaceutical companies in India are producing substandard drugs, failing to meet safety standards. Inspections have uncovered issues with infrastructure, quality management, and manufacturing processes. A significant percentage of MSMEs have faced stop production orders due to these quality concerns, prompting calls for stricter GMP regulations.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/RV0IqHS
via IFTTT